| Trial ID: | L6091 |
| Source ID: | NCT02767596
|
| Associated Drug: |
Lixisenatide
|
| Title: |
Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Lixisenatide|DRUG: Basal insulins
|
| Outcome Measures: |
Primary: Change in hemoglobin A1c, 16 weeks|Change in body weight, 16 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Laniado Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
2
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-07-12
|
| Completion Date: |
2017-02-21
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-07
|
| Locations: |
Bildirici Diabetes Center, Laniado Hospital, Netanya, 42150, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT02767596
|
